Northern Trust’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Northern Trust’s Portfolio BTTX Stock Details BTTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-16,703	Closed	-$3.26K	–	4511
2023 Q4	$3.26K	Hold	16,703	–	–	﹤0.01%	4466
2023 Q3	$6.11K	Hold	16,703	–	–	﹤0.01%	4424
2023 Q2	$18K	Hold	16,703	–	–	﹤0.01%	4425
2023 Q1	$11.7K	Hold	16,703	–	–	﹤0.01%	4510
2022 Q4	$18.5K	Hold	16,703	–	–	﹤0.01%	4506
2022 Q3	$29K	Hold	16,703	–	–	﹤0.01%	4472
2022 Q2	$26K	Hold	16,703	–	–	﹤0.01%	4583
2022 Q1	$33K	Hold	16,703	–	–	﹤0.01%	4604
2021 Q4	$78K	Buy	+16,703	New	+$137K	﹤0.01%	4494

Other funds holding BTTX

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

APC

Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

Northern Trust's BTTX Position: Q1 2024 in Review

Northern Trust sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q1 2024, closing a stake of 16,703 shares — an estimated $3.26K sold.

Northern Trust first reported a position in BTTX in Q4 2021 and held it in 9 quarters. The position peaked at $78K in Q4 2021. 3 funds tracked by Wall St. Rank hold BTTX as of Q1 2024.

Northern Trust reported no remaining Better Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Northern Trust sold 16,703 Better Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.26K.
Northern Trust first reported a position in Better Therapeutics, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
Northern Trust's Better Therapeutics, Inc. Common Stock position peaked at $78K in Q4 2021.
3 funds tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.